A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics

Glycopeptide antibiotics (GPAs) are drugs of last resort for treating infections by Gram-positive bacteria. They inhibit bacterial cell wall assembly by binding to the <span style="font-variant: small-caps;">d</span>-Ala-<span style="font-variant: small-caps;">d...

Full description

Bibliographic Details
Main Authors: Aurora Montali, Francesca Berini, Maurizio Francesco Brivio, Maristella Mastore, Alessio Saviane, Silvia Cappellozza, Flavia Marinelli, Gianluca Tettamanti
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/6/300
_version_ 1827715665560076288
author Aurora Montali
Francesca Berini
Maurizio Francesco Brivio
Maristella Mastore
Alessio Saviane
Silvia Cappellozza
Flavia Marinelli
Gianluca Tettamanti
author_facet Aurora Montali
Francesca Berini
Maurizio Francesco Brivio
Maristella Mastore
Alessio Saviane
Silvia Cappellozza
Flavia Marinelli
Gianluca Tettamanti
author_sort Aurora Montali
collection DOAJ
description Glycopeptide antibiotics (GPAs) are drugs of last resort for treating infections by Gram-positive bacteria. They inhibit bacterial cell wall assembly by binding to the <span style="font-variant: small-caps;">d</span>-Ala-<span style="font-variant: small-caps;">d</span>-Ala terminus of peptidoglycan precursors, leading to cell lysis. Vancomycin and teicoplanin are first generation GPAs, while dalbavancin is one of the few, recently approved, second generation GPAs. In this paper, we developed an in vivo insect model to compare, for the first time, the efficacy of these three GPAs in curing <i>Staphylococcus aureus</i> infection. Differently from previous reports, <i>Bombyx mori</i> larvae were reared at 37 °C, and the course of infection was monitored, following not only larval survival, but also bacterial load in the insect body, hemocyte activity, phenoloxidase activity, and antimicrobial peptide expression. We demonstrated that the injection of <i>S. aureus</i> into the hemolymph of <i>B. mori</i> larvae led to a marked reduction of their survival rate within 24–48 h. GPAs were not toxic to the larvae and cured <i>S. aureus</i> infection. Dalbavancin was more effective than first generation GPAs. Due to its great advantages (i.e., easy and safe handling, low rearing costs, low antibiotic amount needed for the tests, no restrictions imposed by ethical and regulatory issues), this silkworm infection model could be introduced in preclinical phases—prior to the use of mice—accelerating the discovery/development rate of novel GPAs.
first_indexed 2024-03-10T19:23:09Z
format Article
id doaj.art-c2e4375bb4264df2b17744433e7c6226
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T19:23:09Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-c2e4375bb4264df2b17744433e7c62262023-11-20T02:50:46ZengMDPI AGAntibiotics2079-63822020-06-019630010.3390/antibiotics9060300A Silkworm Infection Model for In Vivo Study of Glycopeptide AntibioticsAurora Montali0Francesca Berini1Maurizio Francesco Brivio2Maristella Mastore3Alessio Saviane4Silvia Cappellozza5Flavia Marinelli6Gianluca Tettamanti7Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, ItalyDepartment of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, ItalyDepartment of Theoretical and Applied Sciences, University of Insubria, 21100 Varese, ItalyDepartment of Theoretical and Applied Sciences, University of Insubria, 21100 Varese, ItalyCouncil for Agricultural Research and Economics, Research Centre for Agriculture and Environment (CREA-AA), 35143 Padova, ItalyCouncil for Agricultural Research and Economics, Research Centre for Agriculture and Environment (CREA-AA), 35143 Padova, ItalyDepartment of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, ItalyDepartment of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, ItalyGlycopeptide antibiotics (GPAs) are drugs of last resort for treating infections by Gram-positive bacteria. They inhibit bacterial cell wall assembly by binding to the <span style="font-variant: small-caps;">d</span>-Ala-<span style="font-variant: small-caps;">d</span>-Ala terminus of peptidoglycan precursors, leading to cell lysis. Vancomycin and teicoplanin are first generation GPAs, while dalbavancin is one of the few, recently approved, second generation GPAs. In this paper, we developed an in vivo insect model to compare, for the first time, the efficacy of these three GPAs in curing <i>Staphylococcus aureus</i> infection. Differently from previous reports, <i>Bombyx mori</i> larvae were reared at 37 °C, and the course of infection was monitored, following not only larval survival, but also bacterial load in the insect body, hemocyte activity, phenoloxidase activity, and antimicrobial peptide expression. We demonstrated that the injection of <i>S. aureus</i> into the hemolymph of <i>B. mori</i> larvae led to a marked reduction of their survival rate within 24–48 h. GPAs were not toxic to the larvae and cured <i>S. aureus</i> infection. Dalbavancin was more effective than first generation GPAs. Due to its great advantages (i.e., easy and safe handling, low rearing costs, low antibiotic amount needed for the tests, no restrictions imposed by ethical and regulatory issues), this silkworm infection model could be introduced in preclinical phases—prior to the use of mice—accelerating the discovery/development rate of novel GPAs.https://www.mdpi.com/2079-6382/9/6/300insect infection model<i>Bombyx mori</i>glycopeptide antibioticsvancomycinteicoplanindalbavancin
spellingShingle Aurora Montali
Francesca Berini
Maurizio Francesco Brivio
Maristella Mastore
Alessio Saviane
Silvia Cappellozza
Flavia Marinelli
Gianluca Tettamanti
A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics
Antibiotics
insect infection model
<i>Bombyx mori</i>
glycopeptide antibiotics
vancomycin
teicoplanin
dalbavancin
title A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics
title_full A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics
title_fullStr A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics
title_full_unstemmed A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics
title_short A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics
title_sort silkworm infection model for in vivo study of glycopeptide antibiotics
topic insect infection model
<i>Bombyx mori</i>
glycopeptide antibiotics
vancomycin
teicoplanin
dalbavancin
url https://www.mdpi.com/2079-6382/9/6/300
work_keys_str_mv AT auroramontali asilkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT francescaberini asilkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT mauriziofrancescobrivio asilkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT maristellamastore asilkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT alessiosaviane asilkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT silviacappellozza asilkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT flaviamarinelli asilkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT gianlucatettamanti asilkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT auroramontali silkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT francescaberini silkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT mauriziofrancescobrivio silkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT maristellamastore silkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT alessiosaviane silkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT silviacappellozza silkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT flaviamarinelli silkworminfectionmodelforinvivostudyofglycopeptideantibiotics
AT gianlucatettamanti silkworminfectionmodelforinvivostudyofglycopeptideantibiotics